Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers

Daniel L. Faden, Sarah T. Arron, Chase M. Heaton, Joseph Derisi, Andrew P. South, Steven J. Wang

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Background: Little is known regarding the etiology and genomic underpinnings of Oral Tongue Squamous Cell Carcinoma (OTSCC) in patients who lack traditional risk factors, yet the incidence is increasing. In particular, the rate, and role, of TP53 mutations in this cohort has been heavily debated in the literature. Methods: Tumor DNA from forty-three non-smokers with OTSCC underwent next generation sequencing of TP53. Results: Sixty percent of samples contained a TP53 mutation. The G > T transversion rate was 5.7 %. TP53 status did not differ by age. Conclusions: OTSCC in non-smokers have TP53 mutation rates similar to other Head and Neck cancers yet these mutations do not appear related to carcinogen exposure based on the mutational spectrum and clinical history. The mechanisms driving tumorigenesis in this cohort, including mutations in TP53, remain elusive and further studies are needed.

Original languageEnglish (US)
Article number47
JournalJournal of Otolaryngology - Head and Neck Surgery
Issue number1
StatePublished - Sep 17 2016
Externally publishedYes


  • Oral tongue carcinoma
  • TP53

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this